Skip to main contentUnresolvableMixed ResultMixed ResultDefendant WinDefendant Win
Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/s
U.S. Supreme CourtApril 17, 2012No. 10-844Cited 207 times
Plaintiff WinNovo Nordisk A/S
Case Details
- Judge(s)
- Sotomayor, Kagan, Sotomayok
- Status
- Published
- Procedural Posture
- Supreme Court decision reversing Federal Circuit
- Circuit
- Federal Circuit
Related Laws
No specific laws identified for this ruling.
Outcome
The Supreme Court reversed the Federal Circuit's decision, holding that Novo Nordisk's patents were unenforceable due to inequitable conduct before the Patent Office in failing to disclose material information about prior art.
Similar Rulings
Jean Adams v. Novo Nordisk A/S
9th CircuitMar 2022
Novo Nordisk A/s v. Caraco Pharmaceutical Laboratories, Ltd.
Federal CircuitMay 2012
Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S
U.S. Supreme CourtNov 2011
Metabolite Laboratories, Inc. And Competitive Technologies, Inc. v. Laboratory Corporation of America Holdings (Doing Business as Labcorp)
Federal CircuitJun 2004
Laboratory Corp. of America Holdings v. Metabolite Laboratories, Inc.
U.S. Supreme CourtJun 2006
Facing something similar at work?
Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.
This ruling information is sourced from public court records via CourtListener.com. It is provided for informational and educational purposes only and does not constitute legal advice.